PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20577121-2	2010	This systematic review and meta-analysis was performed to clarify the effects of soy isoflavone extract supplements on systolic and diastolic blood pressure (SBP and DBP) in adult humans.	Isoflavones	85-95	selenium binding protein 1	Homo sapiens	158-161	
20577121-7	2010	Daily ingestion of 25-375 mg soy isoflavones (aglycone equivalents) for 2-24 weeks significantly decreased SBP by 1.92 mmHg (95% confidence interval -3.45 to -0.39; P = 0.01) compared with placebo (heterogeneity P = 0.39, fixed effect model) in adults with normal blood pressure and prehypertension.	Isoflavones	33-44	selenium binding protein 1	Homo sapiens	107-110	
20577121-11	2010	CONCLUSION: Soy isoflavone extracts significantly decreased SBP but not DBP in adult humans, and no dose-response relationship was observed.	Isoflavones	16-26	selenium binding protein 1	Homo sapiens	60-63	
20577121-12	2010	Further studies are needed to address factors related to the observed effects of soy isoflavones on SBP and to verify the effect in hypertensive patients.	Isoflavones	85-96	selenium binding protein 1	Homo sapiens	100-103	
23203140-6	2013	However, a subgroup analysis among 130 pre and hypertensive women suggested that soy protein and isoflavones significantly reduced SBP [-4.25%, 95% confidence interval (CI) -7.9 to -0.6%, P = 0.02] and the level of soluble intercellular adhesion molecule (sICAM)-1 (-22.6%, 95% CI -42.8 to -2.3%, P = 0.02) relative to milk protein after 6-month intervention.	Isoflavones	97-108	selenium binding protein 1	Homo sapiens	131-134